Why Ironwood $IRWD will Make Your Port Hard (Your Next 3x Biotech/Pharma Play)

So before you go sleuthing through my profile, my 10+ year old account got nuked recently over some mildly controversial comments...So now I have this baby account and I'm not a bot and just want to put that out there first.

Anyway, onto the DD...

I'll keep this short, over the past few weeks, IRWD has seen two pieces of news that aren’t huge on their own, but together meaningfully improve the stock.

Linzess sales blowout

* \-Q3 Linzess sales came in at **\~$315–350M vs. \~$250M expected**
* \-Ironwood receives **\~33% of Linzess sales**
* \-That translates to **\~$104M in revenue this quarter**, up from **\~$85M last quarter**
* \-That’s roughly **+$20M per quarter**, or **\~$80M annually**, above expectations
* \-This was a much larger jump than anticipated and strengthens profitability going forward

Pediatric label expansion

* \-Linzess received FDA label expansion for pediatric patients
* \-This makes Linzess the first drug available for this pediatric indication
* \-Expands the addressable market with limited competition
* \-Should further support future sales growth

In Summery

* \-Both updates are clearly bullish
* \-Revenue is already strong and now has an added tailwind
* \-There’s currently very little bearish news in the near term
* \-The next key catalyst will be the **upcoming quarterly report**, especially any updates on the pipeline
* \-There is mostly upswing with a potential of 2x-3x in the next 6 months.

That's it, pretty simple and easy play that I can see.

Not financial advice — do your own DD. Good luck!

My positions: [https://ibb.co/mrc8HRdp](https://ibb.co/mrc8HRdp)